ePI Transformation
Paper leaflets, reimagined as structured digital data.
Electronic Product Information is the future of medication leaflets in Europe. Leaphy is the platform that gets you there — without disrupting your workflow.
Why ePI
A pan-European push for digital leaflets.
Endorsed by the EMA, EFPIA, AESGP, PGEU and Medicines for Europe — ePI brings clarity, accessibility and safety to every leaflet, in every language.
1 in 3
patients struggle to read paper leaflets due to font size and density.
26
official EU languages — ePI keeps every translation perfectly in sync.
Real-time
safety updates reach patients and HCPs the moment they're approved.
The Leaphy pipeline
From approval to patient — in five steps.
A repeatable, audit-friendly process that turns regulatory documents into structured ePI ready for every channel.
- Step 01
Approved leaflet
We start from the latest regulatory-approved PDF/Word leaflet from the marketing authorisation holder.
- Step 02
Structured parsing
Each leaflet is parsed into chapters and fields using our ePI templates aligned with ISO IDMP.
- Step 03
Enriched & stored
We attach ATC5 classification, structured metadata, language, market and product context. Stored securely on Azure.
- Step 04
Multilingual sync
Content is delivered in all relevant EU languages, with version control and change tracking.
- Step 05
Multichannel delivery
Pushed to the Leaphy app, your website, partner channels — or directly via API.
Compliance
Built around the standards that matter.
Our metadata follows the Falsified Medicines Directive (FMD) and ISO IDMP, so every product is identified consistently across markets — and every update is traceable.
- FMD compliant
- ISO IDMP aligned
- EMA-style chapters
- GDPR by default
- Azure-hosted
- Version controlled
Start your ePI transformation.
Whether you're at strategy or rollout — we'd love to show you what the next generation of medication information looks like.